ACKR3 and glioblastoma: We originally identified CXCR7 (then called RDC1) as a selective marker of glioblastoma (GBM) derived microvascular endothelial cells and confirmed that it was induced in the tumor endothelium of both primary and metastatic malignant brain tumors [18], [19].